Overview

Dupilumab Asthma Sleep Study

Status:
Recruiting
Trial end date:
2022-09-14
Target enrollment:
Participant gender:
Summary
Primary Objective: To assess the effect of dupilumab on sleep Secondary Objectives: - To evaluate the effect of dupilumab on additional patient reported sleep outcomes - To evaluate the effect of dupilumab on objective sleep assessment - To evaluate the effect of dupilumab on asthma symptoms - To evaluate the effect of dupilumab on lung function - To evaluate the safety of dupilumab
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Collaborator:
Regeneron Pharmaceuticals